Subcutaneous bortezomib is highly effective for pure red cell aplasia after ABO-incompatible haematopoietic stem cell transplantation
Author:
Affiliation:
1. Department of Hematology; Oncology and Transplantation
2. Department of Pathology; University of Minnesota; Minneapolis MN 55455 USA
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/tme.12121/fullpdf
Reference5 articles.
1. Clinical guide to ABO-incompatible allogeneic stem cell transplantation;Booth;Biology of Blood and Marrow Transplantion,2013
2. Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation;Griffith;British Journal of Haematology,2005
3. Successful treatment of isohemagglutinin-mediated pure red cell aplasia after ABO-mismatched allogeneic hematopoietic cell transplant using bortezomib;Poon;Bone Marrow Transplantation,2012
4. Diagnosis and management of acquired pure red cell aplasia;Sawada;Hematology/Oncology Clinics of North America,2009
5. Successful treatment of severe ABO antibody-mediated rejection using bortezomib: a case report;Westphal;Transplantation Proceedings,2013
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Seven-years post allogeneic hematopoietic stem cell transplantation pure red cell aplastic anemia cured with daratumumab: A case report and review of literature;World Journal of Clinical Cases;2024-08-26
2. Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab;Transfusion;2024-02-13
3. Refractory Pure Red Blood Cell Aplasia Secondary to Major ABO-Incompatible Allogeneic Stem Cell Transplantation Successfully Treated With Daratumumab;Journal of Hematology;2023-12
4. Multiple modalities in treating pediatric pure red cell aplasia: A case series;Pediatric Hematology Oncology Journal;2023-09
5. Non-prise de greffe, dysfonctionnement du greffon et érythroblastopénie : mise à jour des définitions, outils diagnostiques et prise en charge : recommandation de la SFGM-TC;Bulletin du Cancer;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3